![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
M Bouvier, M Hnatowich, S Collins, BK Kobilka, A Deblasi, RJ Lefkowitz and MG Caron
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
A human beta-adrenergic receptor cDNA was transfected and expressed in transformed Chinese hamster fibroblasts (CHW). The expressed receptor exhibited a typical beta 2-adrenergic selectivity for agonists and antagonists as assessed by radioligand binding and adenylate cyclase activation. Guanine nucleotide-sensitive high affinity binding of the agonist, isoproterenol, indicated effective coupling of the expressed receptor to a guanine nucleotide-regulatory protein. The level of expression of beta 2-AR in various cell clones varied over 200-fold and was positively correlated with the levels of beta 2-AR mRNA. In cells expressing between 0.04 and 3.0 pmol of beta 2-AR/mg of membrane protein, the efficacy of isoproterenol for stimulating adenylate cyclase increased with increasing numbers of expressed receptors but reached a plateau and started to decrease in clones with higher beta 2- AR density (3.0-8.0 pmol/mg of membrane protein). Preincubation of beta 2-AR-expressing cells with isoproterenol for 15 min led to significant reduction in the level of isoproterenol-sensitive adenylate cyclase activity. This agonist-induced desensitization was also accompanied by phosphorylation of the beta 2-AR. These data indicate that the expressed human beta 2-AR displays typical functional characteristics of adenylate cyclase-coupled receptors including agonist-induced desensitization. Moreover, the availability of this series of cellular clones, which differ markedly in their density of beta 2-AR, provides a unique set of biological reagents for future studies of beta 2-AR function and regulation.
This article has been cited by other articles:
|
|
 |
|
  A. M. Zamah, M. Delahunty, L. M. Luttrell, and R. J. Lefkowitz Protein Kinase A-mediated Phosphorylation of the beta 2-Adrenergic Receptor Regulates Its Coupling to Gs and Gi. DEMONSTRATION IN A RECONSTITUTED SYSTEM J. Biol. Chem., August 16, 2002; 277(34): 31249 - 31256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Loisel, H. Ansanay, L. Adam, S. Marullo, R. Seifert, M. Lagace, and M. Bouvier Activation of the beta 2-Adrenergic Receptor-Galpha s Complex Leads to Rapid Depalmitoylation and Inhibition of Repalmitoylation of Both the Receptor and Galpha s J. Biol. Chem., October 22, 1999; 274(43): 31014 - 31019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Adam, M. Bouvier, and T. L. Z. Jones Nitric Oxide Modulates beta 2-Adrenergic Receptor Palmitoylation and Signaling J. Biol. Chem., September 10, 1999; 274(37): 26337 - 26343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gaspo, H. Sun, S. Fareh, M. Levi, L. Yue, B. G. Allen, T. E. Hebert, and S. Nattel Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation Cardiovasc Res, May 1, 1999; 42(2): 434 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Seifert, K. Wenzel-Seifert, T. W. Lee, U. Gether, E. Sanders-Bush, and B. K. Kobilka Different Effects of Gsalpha Splice Variants on beta 2-Adrenoreceptor-mediated Signaling. THE beta 2-ADRENORECEPTOR COUPLED TO THE LONG SPLICE VARIANT OF Gsalpha HAS PROPERTIES OF A CONSTITUTIVELY ACTIVE RECEPTOR J. Biol. Chem., May 1, 1998; 273(18): 5109 - 5116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Seifert, K. Wenzel-Seifert, T. W. Lee, U. Gether, E. Sanders-Bush, and B. K. Kobilka Different Effects of Gsalpha Splice Variants on beta 2-Adrenoreceptor-mediated Signaling. THE beta 2-ADRENORECEPTOR COUPLED TO THE LONG SPLICE VARIANT OF Gsalpha HAS PROPERTIES OF A CONSTITUTIVELY ACTIVE RECEPTOR J. Biol. Chem., February 27, 1998; 273(9): 5109 - 5116. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Lacroix, J. Tremblay, G. Rousseau, M. Bouvier, and P. Hamet Propranolol Therapy for Ectopic {beta}-Adrenergic Receptors in Adrenal Cushing's Syndrome N. Engl. J. Med., November 13, 1997; 337(20): 1429 - 1434. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsuda, T. Kusui, W. Hou, R. V. Benya, M. A. Akeson, G. S. Kroog, J. F. Battey, and R. T. Jensen Effect of Gastrin-Releasing Peptide Receptor Number on Receptor Affinity, Coupling, Degradation, and Modulation Mol. Pharmacol., May 1, 1997; 51(5): 721 - 732. [Abstract] [Full Text]
|
|
|
|
|
|
S. Moffett, L. Adam, H. Bonin, T. P. Loisel, M. Bouvier, and B. Mouillac Palmitoylated Cysteine 341Modulates Phosphorylation of the beta 2-Adrenergic Receptor by the cAMP-dependent Protein Kinase J. Biol. Chem., August 30, 1996; 271(35): 21490 - 21497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Hebert, S. Moffett, J.-P. Morello, T. P. Loisel, D. G. Bichet, C. Barret, and M. Bouvier A Peptide Derived from a beta 2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation J. Biol. Chem., July 5, 1996; 271(27): 16384 - 16392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Angers, A. Salahpour, E. Joly, S. Hilairet, D. Chelsky, M. Dennis, and M. Bouvier Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) PNAS, March 28, 2000; 97(7): 3684 - 3689. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
